June 25, 2020 / 11:45 AM / 9 days ago

Moderna names Catalent as manufacturing partner for potential COVID-19 vaccine

June 25 (Reuters) - Moderna Inc said on Thursday it has partnered with contract drugmaker Catalent Inc to produce 100 million doses of its experimental COVID-19 vaccine starting in the third quarter of 2020.

Under the deal, Catalent would also provide packaging and labeling, storage and distribution services to support Moderna's late-stage clinical trial for the vaccine. (reut.rs/384fCLt) (Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Shailesh Kuber)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below